Aliskiren inhibited atherosclerosis development and improved plaque stability alone and in combination with atorvastatin, possibly via a mechanism involving T cells.
These results suggest a potential benefit of using aliskiren in a clinical setting, particularly in combination with statin treatment.
2011-12-14
Eng.
TNO Metabolic Health Research, Leiden University Medical Center, Leiden, The Netherlands. susan.jordaan [at] tno.nl
J Hypertens. 2012 Jan;30(1):107-16
© Galenicom 1999-2013